PubRank
Search
About
Jörg J Goronzy
Author PubWeight™ 139.35
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The influence of age on T cell generation and TCR diversity.
J Immunol
2005
4.36
2
Medium- and large-vessel vasculitis.
N Engl J Med
2003
3.96
3
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Arthritis Rheum
2006
3.64
4
Giant-cell arteritis and polymyalgia rheumatica.
Ann Intern Med
2003
3.48
5
Clinical practice. Giant-cell arteritis and polymyalgia rheumatica.
N Engl J Med
2014
3.46
6
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.
J Acquir Immune Defic Syndr
2012
2.95
7
T cell subset-specific susceptibility to aging.
Clin Immunol
2008
2.42
8
The immunopathology of giant cell arteritis: diagnostic and therapeutic implications.
J Neuroophthalmol
2012
2.19
9
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity.
Nat Med
2012
2.19
10
Vessel-specific Toll-like receptor profiles in human medium and large arteries.
Circulation
2008
1.91
11
Th17 and Th1 T-cell responses in giant cell arteritis.
Circulation
2010
1.88
12
Therapeutic effects of acetylsalicylic acid in giant cell arteritis.
Arthritis Rheum
2002
1.80
13
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha.
Circulation
2006
1.77
14
Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque.
Circ Res
2006
1.77
15
BLyS and APRIL in rheumatoid arthritis.
J Clin Invest
2005
1.75
16
Regulation of T cell receptor signaling by activation-induced zinc influx.
J Exp Med
2011
1.73
17
T-cell-mediated lysis of endothelial cells in acute coronary syndromes.
Circulation
2002
1.72
18
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis.
J Exp Med
2004
1.70
19
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.
Circulation
2010
1.68
20
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages.
Proc Natl Acad Sci U S A
2003
1.65
21
T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome.
Circ Res
2006
1.62
22
Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells.
Blood
2009
1.62
23
Homeostatic control of T-cell generation in neonates.
Blood
2003
1.62
24
Immune activation caused by vascular oxidation promotes fibrosis and hypertension.
J Clin Invest
2015
1.55
25
Telomerase insufficiency in rheumatoid arthritis.
Proc Natl Acad Sci U S A
2009
1.54
26
Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis.
J Exp Med
2009
1.54
27
NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.
J Clin Invest
2016
1.53
28
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque.
J Exp Med
2006
1.48
29
Immune mechanisms in medium and large-vessel vasculitis.
Nat Rev Rheumatol
2013
1.48
30
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection.
Trends Mol Med
2004
1.47
31
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque.
Circulation
2007
1.47
32
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study.
Arthritis Res Ther
2005
1.38
33
Immunosenescence, autoimmunity, and rheumatoid arthritis.
Exp Gerontol
2003
1.38
34
CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis.
J Exp Med
2002
1.38
35
Toll-like receptors 4 and 5 induce distinct types of vasculitis.
Circ Res
2009
1.37
36
Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation.
Circ Res
2008
1.35
37
Functional profile of activated dendritic cells in unstable atherosclerotic plaque.
Basic Res Cardiol
2006
1.34
38
Rejuvenating the immune system in rheumatoid arthritis.
Nat Rev Rheumatol
2009
1.29
39
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.
Atherosclerosis
2006
1.26
40
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis.
Curr Opin Rheumatol
2011
1.26
41
Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis.
Arthritis Rheum
2008
1.25
42
Inhibitory CD8+ T cells in autoimmune disease.
Hum Immunol
2008
1.23
43
DNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis.
EMBO Mol Med
2010
1.23
44
Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.
J Immunol
2004
1.23
45
Telomeres and immunological diseases of aging.
Gerontology
2009
1.22
46
Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.
J Immunol
2007
1.22
47
CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation.
Blood
2002
1.21
48
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
Autoimmun Rev
2004
1.20
49
Telomere dysfunction, autoimmunity and aging.
Aging Dis
2011
1.20
50
Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis.
Am J Pathol
2002
1.19
51
Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells.
J Exp Med
2003
1.18
52
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.
Arthritis Res Ther
2005
1.17
53
Formation of the killer Ig-like receptor repertoire on CD4+CD28null T cells.
J Immunol
2002
1.15
54
De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes.
Circ Res
2003
1.15
55
Vascular dendritic cells in giant cell arteritis.
Ann N Y Acad Sci
2005
1.14
56
Chronic inflammation and aging: DNA damage tips the balance.
Curr Opin Immunol
2012
1.13
57
Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis.
Circulation
2011
1.12
58
Molecular basis for the loss of CD28 expression in senescent T cells.
J Biol Chem
2002
1.11
59
Peripheral selection rather than thymic involution explains sudden contraction in naive CD4 T-cell diversity with age.
Proc Natl Acad Sci U S A
2012
1.11
60
CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.
J Immunol
2012
1.10
61
T cells in arteritis and atherosclerosis.
Curr Opin Lipidol
2008
1.10
62
Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors.
Blood
2006
1.09
63
TLR-mediated induction of negative regulatory ligands on dendritic cells.
J Mol Med (Berl)
2008
1.09
64
Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age.
Proc Natl Acad Sci U S A
2012
1.08
65
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
Arthritis Rheum
2005
1.08
66
Lymphotoxin beta-mediated stimulation of synoviocytes in rheumatoid arthritis.
Arthritis Rheum
2004
1.08
67
Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells.
J Biol Chem
2005
1.07
68
ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis.
J Immunol
2009
1.06
69
Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis.
J Immunol
2005
1.05
70
T-cell aging in rheumatoid arthritis.
Curr Opin Rheumatol
2014
1.04
71
Toll-like receptors in giant cell arteritis.
Clin Immunol
2005
1.04
72
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.
Arthritis Rheum
2006
1.01
73
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis.
Am J Pathol
2004
1.01
74
Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells.
J Leukoc Biol
2008
1.00
75
IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens.
J Immunol
2013
0.99
76
Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis.
Arthritis Rheum
2005
0.99
77
T-cell-targeted therapies in rheumatoid arthritis.
Nat Clin Pract Rheumatol
2006
0.98
78
Stem cell aging and autoimmunity in rheumatoid arthritis.
Trends Mol Med
2004
0.98
79
B cells in rheumatoid synovitis.
Arthritis Res Ther
2005
0.98
80
Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis.
Arthritis Rheum
2007
0.97
81
Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction.
J Immunol
2003
0.97
82
The double life of NK receptors: stimulation or co-stimulation?
Trends Immunol
2004
0.97
83
Giant cell arteritis: immune and vascular aging as disease risk factors.
Arthritis Res Ther
2011
0.95
84
Vascular damage in giant cell arteritis.
Autoimmunity
2009
0.95
85
Synoviocyte stimulation by the LFA-1-intercellular adhesion molecule-2-Ezrin-Akt pathway in rheumatoid arthritis.
J Immunol
2008
0.94
86
Mechanisms of immunosenescence: lessons from models of accelerated immune aging.
Ann N Y Acad Sci
2012
0.93
87
Macrophages in vascular inflammation--From atherosclerosis to vasculitis.
Autoimmunity
2015
0.91
88
Lymphoma in rheumatoid arthritis: an immune system set up for failure.
Arthritis Rheum
2006
0.89
89
Age-dependent signature of metallothionein expression in primary CD4 T cell responses is due to sustained zinc signaling.
Rejuvenation Res
2008
0.89
90
Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries.
Am J Pathol
2002
0.88
91
Finding Balance: T cell Regulatory Receptor Expression during Aging.
Aging Dis
2011
0.86
92
Magnetic resonance angiography in extracranial giant cell arteritis.
J Clin Rheumatol
2011
0.85
93
K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis.
Proc Natl Acad Sci U S A
2012
0.85
94
Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription.
J Biol Chem
2004
0.85
95
Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome.
Circ Res
2009
0.84
96
A population biological approach to understanding the maintenance and loss of the T-cell repertoire during aging.
Immunology
2014
0.83
97
Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages.
Blood
2010
0.81
98
Autophagy in autoimmune disease.
J Mol Med (Berl)
2015
0.81
99
Premature immunosenescence in rheumatoid arthritis.
J Rheumatol
2002
0.81
100
Dampened ERK signaling in hematopoietic progenitor cells in rheumatoid arthritis.
Clin Immunol
2012
0.80
101
Pathogenic mechanisms in giant cell arteritis.
Cleve Clin J Med
2002
0.80
102
Immune senescence.
Curr Opin Immunol
2010
0.79
103
Immunosuppression in atherosclerosis: mobilizing the opposition within.
Circulation
2006
0.79
104
B cells as a therapeutic target in autoimmune diseases.
Expert Opin Ther Targets
2005
0.78
105
Immune activation caused by vascular oxidation promotes fibrosis and hypertension.
J Clin Invest
2016
0.77
106
Pathomechanisms in rheumatoid arthritis--time for a string theory?
J Clin Invest
2006
0.77
107
Biology of T lymphocytes.
Rheum Dis Clin North Am
2004
0.76
108
Treatment of chronic inflammatory diseases with biologic agents: opportunities and risks for the elderly.
Exp Gerontol
2006
0.75
109
HLA-DRB1 haplotype did not affect the medium-term results of total knee arthroplasty in patients with rheumatoid arthritis.
Mod Rheumatol
2004
0.75
110
Lipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease.
Future Cardiol
2005
0.75
111
Bi-directional modulation of T cell-dependent antibody production by prostaglandin E(2).
Int Immunol
2002
0.75